Odyssey Therapeutics, Inc. (ODTX)
NASDAQ: ODTX · Real-Time Price · USD
17.62
+0.30 (1.73%)
At close: May 15, 2026, 4:00 PM EDT
17.97
+0.35 (1.99%)
After-hours: May 15, 2026, 6:32 PM EDT
Odyssey Therapeutics Market Cap
Odyssey Therapeutics has a market cap or net worth of $831.21 million as of May 15, 2026.
Market Cap
831.21M
Enterprise Value
640.35M
1-Year Change
n/a
Ranking
Category
Stock Price
$17.62
Market Cap Chart
Since May 8, 2026, Odyssey Therapeutics's market cap has increased from $474.43M to $831.21M, an increase of 75.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 509.10M | 1.73% |
| May 14, 2026 | 500.43M | -3.46% |
| May 13, 2026 | 518.34M | 0.22% |
| May 12, 2026 | 517.19M | 2.58% |
| May 11, 2026 | 504.19M | 6.27% |
| May 8, 2026 | 474.43M | - |
View and export this data all the way back to 2026. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sana Biotechnology | 854.36M |
| Annexon | 853.62M |
| LB Pharmaceuticals | 850.55M |
| Janux Therapeutics | 847.07M |
| ORIC Pharmaceuticals | 843.67M |
| Arbutus Biopharma | 837.56M |
| Theravance Biopharma | 836.19M |
| Xencor | 831.87M |